The market is dominated by domestic suppliers, as imports account for 26.7% of total market size in 2022. B2B drives market demand, with B2B spending representing 86.8% of total demand in 2022. South Korea has the third largest market size for pharmaceuticals regionally, with demand reaching USD44.6 billion in 2022. Yuhan Corp is the largest company in South Korea, generating 5.8% of the industry’s total production value in 2022. The industry is fragmented, with the top five companies generating 19.1% of total production value in 2022. The total number of companies increases in 2022, to 943 units. The costs of the industry decrease by 3.9% in 2022, largely driven by declining B2B costs. The industry’s profitability increases and stands at 20.4% of production value in 2022, the seventh highest regionally. The industry’s exports share decreases in 2022 to 16.6% of total production output. With production value of USD31.5 billion, South Korea accounts for 4.2% of the Asia Pacific total in 2022.
Delivery:
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
This report comes in PDF.
This Euromonitor industrial report provides unique information on Pharmaceuticals in South Korea: ISIC 2423. With this industrial report, you’ll be able to explore the industry from its sources of supply to its buyers. The Pharmaceuticals in South Korea: ISIC 2423 report includes: Industry datagraphics including production data, exports, imports, cost structure, and profitability
Pharmaceuticals and Medical Equipment is an aggregation of Pharmaceuticals, Medical and Surgical Equipment.
See All of Our DefinitionsIf you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!